CA2343696A1 - Proteines organisationnelles associees aux membranes - Google Patents
Proteines organisationnelles associees aux membranes Download PDFInfo
- Publication number
- CA2343696A1 CA2343696A1 CA002343696A CA2343696A CA2343696A1 CA 2343696 A1 CA2343696 A1 CA 2343696A1 CA 002343696 A CA002343696 A CA 002343696A CA 2343696 A CA2343696 A CA 2343696A CA 2343696 A1 CA2343696 A1 CA 2343696A1
- Authority
- CA
- Canada
- Prior art keywords
- hjnct
- polynucleotide
- ser
- leu
- ala
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pain & Pain Management (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
La présente invention concerne d'une part des protéines organisationnelles d'origine humaine (HJNCT) associées aux membranes ainsi que des polynucléotides qui identifient les HJNCT. L'invention concerne d'autre part des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes. L'invention concerne enfin le diagnostic, le traitement et la prévention de troubles liés à l'expression des HJNCT.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15521598P | 1998-09-25 | 1998-09-25 | |
US60/155,215 | 1998-09-25 | ||
US15525198P | 1998-10-13 | 1998-10-13 | |
US60/155,251 | 1998-10-13 | ||
US17222899P | 1999-05-04 | 1999-05-04 | |
US60/172,228 | 1999-05-04 | ||
PCT/US1999/022082 WO2000018915A2 (fr) | 1998-09-25 | 1999-09-23 | Proteines organisationnelles associees aux membranes |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2343696A1 true CA2343696A1 (fr) | 2000-04-06 |
Family
ID=27387692
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002343696A Abandoned CA2343696A1 (fr) | 1998-09-25 | 1999-09-23 | Proteines organisationnelles associees aux membranes |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1115860A2 (fr) |
JP (1) | JP2002525113A (fr) |
AU (1) | AU6260399A (fr) |
CA (1) | CA2343696A1 (fr) |
WO (1) | WO2000018915A2 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001066740A2 (fr) * | 2000-03-03 | 2001-09-13 | Genentech, Inc. | Compositions et methodes de traitement de maladies d'origine immune |
US6573068B1 (en) | 1997-11-13 | 2003-06-03 | Genset, S. A. | Claudin-50 protein |
CA2420140A1 (fr) * | 2000-08-24 | 2002-02-28 | Genentech, Inc. | Compositions et procedes de diagnostic et traitement de tumeurs |
KR101294725B1 (ko) * | 2010-12-30 | 2013-08-08 | 연세대학교 산학협력단 | 인산화된 grasp를 포함하는 낭포성섬유증 치료용 약학 조성물 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998040407A1 (fr) * | 1997-03-14 | 1998-09-17 | Johns Hopkins University | Compositions proteiques a activation synaptique et methode afferente |
-
1999
- 1999-09-23 EP EP99949810A patent/EP1115860A2/fr not_active Withdrawn
- 1999-09-23 JP JP2000572362A patent/JP2002525113A/ja active Pending
- 1999-09-23 AU AU62603/99A patent/AU6260399A/en not_active Abandoned
- 1999-09-23 CA CA002343696A patent/CA2343696A1/fr not_active Abandoned
- 1999-09-23 WO PCT/US1999/022082 patent/WO2000018915A2/fr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2000018915A3 (fr) | 2000-07-27 |
EP1115860A2 (fr) | 2001-07-18 |
WO2000018915A2 (fr) | 2000-04-06 |
AU6260399A (en) | 2000-04-17 |
JP2002525113A (ja) | 2002-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20010010913A1 (en) | Extracellular adhesive proteins | |
CA2347113A1 (fr) | Proteine humaine de la famille des ankyrines | |
US20050214795A1 (en) | Human transcriptional regulator molecules | |
WO2000012711A2 (fr) | Proteines membranaires de canal humaines | |
CA2338386A1 (fr) | Proteases et proteines associees | |
WO2000017355A2 (fr) | Proteines humaines associees au cytosquelette | |
US6265547B1 (en) | Cell junction PDZ protein | |
US6248594B1 (en) | Kinesin-like motor protein | |
WO2000044900A2 (fr) | Proteines liant des acides nucleiques | |
EP1135484A2 (fr) | Proteines associees a la gtpase | |
US6365371B1 (en) | Calcium binding protein | |
CA2343696A1 (fr) | Proteines organisationnelles associees aux membranes | |
CA2332309A1 (fr) | Proteines associees a la neurotransmission | |
US6410267B1 (en) | Human GTPase-associated proteins | |
CA2333467A1 (fr) | Proteine humaine associee a la preseniline | |
US6200790B1 (en) | Vesicle transport associated proteins | |
WO2000006730A2 (fr) | Proteines humaines cytosquelettiques | |
EP1086219A2 (fr) | Proteines regulant l'expression genetique | |
EP1115864A2 (fr) | Proteines chaperons humaines | |
WO2000014248A9 (fr) | Proteines associees a des nucleotides cycliques | |
EP1117781A2 (fr) | Proteines membranaires de canal humaines | |
CA2344657A1 (fr) | Proteine de liaison isre humaine | |
CA2343360A1 (fr) | Proteines humaines associees au cytosquelette | |
CA2345045A1 (fr) | Proteines de recepteurs couples a des proteines g | |
CA2339860A1 (fr) | Proteines humaines de signalisation cellulaire (csig) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |